The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 Current Market Growth

• Market Size 2023: $7.25 billion
• Market Size 2024: $7.66 billion
• CAGR: 5.6%
• Growth Drivers:
  • Increasing government regulations
  • Growing environmental concerns
  • Aging population
  • Patient-centric healthcare approaches
  • Healthcare infrastructure development

Future Market Projections

• Market Size 2028: $9.35 billion
• CAGR: 3.8%
• Growth Drivers:
  • Increasing prevalence of respiratory diseases
  • Rising need for early detection and diagnosis
  • Growing environmental pollution
  • Rising healthcare expenditure
  • Research and development initiatives

View More On The Artificial Intelligence (AI) In Respiratory Diseases Market Report 2024 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

 Technological Advancements

• Key Trends:
  • Technological advancements
  • Drug discovery and development
  • Personalized treatment plans
  • Telemedicine and remote patient monitoring

Addressing Environmental Pollution

• Impact of Pollution:
  • Real-time monitoring
  • Personalized risk assessments
  • Informed decision-making
  • Innovative solutions
• Statistics:
  • 66 million tons of pollution emitted in the US in 2022
  • US greenhouse gas emissions increased by 6,025.97 million metric tons of CO2 in 2020 to 6,340.23 million metric tons of CO2 in 2021
• Example: AI can help reduce respiratory health impacts from pollution by providing real-time data and personalized interventions.

Key Players

• Major Companies:
  • Siemens Healthineers
  • Philips Healthcare
  • General Electric (GE) Healthcare
  • Verily Life Sciences LLC
  • DeepMind Health
  • Merative L.P.
  • Innovaccer
  • Freenome
  • Aidoc Medical
  • Butterfly Network
  • Infervision
  • Imagen Technologies
  • Caption Health

Innovations in Respiratory Disease Management

• TidalSense’s N-Tidal Device:
  • Measures tidal breathing
  • Provides lung function data
  • AI-driven technology for COPD diagnosis and management
  • High accuracy in clinical studies
  • Enhances diagnostic process for respiratory diseases

Strategic Acquisitions

• ResMed Inc. and Somnoware:
  • Acquisition in July 2023
  • Strengthens sleep and respiratory care portfolio
  • Enhances digital respiratory healthcare tools
  • Improves patient data management, treatment equipment ordering, appointment scheduling, and compliance tracking
  • Focus on patient experience and health outcomes

Market Segmentation

• By Imaging Type:
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT) Scan
  • Electronic Patient-Reported Outcomes (ePRO)
• By Indication:
  • Chronic Obstructive Pulmonary Disease
  • Interstitial Lung Disease
  • Pulmonary Infection
• By End Use:
  • Hospital
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Other End-Users

Regional Insights

• Largest Market: North America in 2023
• Fastest-Growing Region: Asia-Pacific in the forecast period

Conclusion

The AI in respiratory diseases market is poised for continued growth, driven by technological advancements, environmental concerns, and the increasing need for early detection and personalized treatment. With major companies innovating and strategic acquisitions enhancing capabilities, the future of AI in respiratory health looks promising.

Request A Sample Of The Global Artificial Intelligence (AI) In Respiratory Diseases Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13792&type=smp